Effects of Perioperative Intravenous Dexamethasone on Pain in Out Patient Knee Surgery
NCT ID: NCT01149616
Last Updated: 2017-07-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
82 participants
INTERVENTIONAL
2009-12-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy
NCT05120076
Preoperative Oral Dexamethasone to Improve Recovery After Surgery
NCT02234466
Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery
NCT03218553
Dexamethasone for Reduction of Post Thoracotomy Pain Syndrome
NCT02112864
Premedication with Intranasal Dexmedetomidine in Sedation of Patients Undergoing Total Knee Arthroplasty
NCT04859283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Dexamethasone 8mg iv x 1
Dexamethasone 8mg iv x1
Dexamethasone 8mg iv x1
Placebo
placebo
placebo
2 ml normal saline IV x1
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethasone 8mg iv x1
Dexamethasone 8mg iv x1
placebo
2 ml normal saline IV x1
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must provide phone contact number and agree to phone followup on post operative day 1
Exclusion Criteria
* Allergy or intolerance to study drug
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beth Israel Deaconess Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lauren J. Fisher
Attending Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lauren Fisher, DO
Role: PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009P000345
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.